Table 1.
Characteristics of participants
| All | HRa | RMSTDa | HR+RMSTDa | |
|---|---|---|---|---|
| N = 469 | N = 160 | N = 154 | N = 155 | |
| Target population | ||||
| Corresponding authors, cancer RCTs | 168 (35.8) | 57 (35.6) | 56 (36.4) | 55 (35.5) |
| Corresponding authors, non-cancer RCTs | 185 (39.5) | 66 (41.2) | 59 (38.3) | 60 (38.7) |
| Medical residents and fellows | 116 (24.7) | 37 (23.1) | 39 (25.3) | 40 (25.8) |
| Ageb | ||||
| 20–29 years | 55 (12.3) | 21 (13.8) | 17 (11.6) | 17 (11.3) |
| 30–39 years | 108 (24.1) | 31 (20.4) | 29 (19.9) | 48 (32.0) |
| 40–49 years | 99 (22.1) | 30 (19.7) | 31 (21.2) | 38 (25.3) |
| 50–59 years | 98 (21.9) | 38 (25.0) | 37 (25.3) | 23 (15.3) |
| 60–69 years | 77 (17.2) | 29 (19.1) | 26 (17.8) | 22 (14.7) |
| 70+ years | 11 (2.4) | 3 (2.0) | 6 (4.1) | 2 (1.3) |
| Genderb | ||||
| Female | 137 (30.4) | 40 (26.1) | 52 (35.4) | 45 (29.8) |
| Male | 312 (69.2) | 112 (73.2) | 94 (63.9) | 106 (70.2) |
| Not listed | 2 (0.4) | 1 (0.7) | 1 (0.7) | 0 (0.0) |
| Prior training in epidemiology/biostatisticsb | ||||
| None | 158 (35.0) | 49 (32.0) | 56 (38.1) | 53 (35.1) |
| Non-degree course | 127 (28.2) | 50 (32.7) | 38 (25.9) | 39 (25.8) |
| Master or PhD | 166 (36.8) | 54 (35.3) | 53 (36.1) | 59 (39.1) |
Data are presented as No. (%).
a
Randomization groups: one of the three versions of the abstract according to the treatment effect measure for the primary outcome: hazard ratio (HR), difference in restricted mean survival times (RMSTD), or both (HR+RMSTD).
b
Missing data n = 21, n = 18, and n = 18 for age, gender, and prior training, respectively.